Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More
Evolve Devices

Business process outsourcing for today

We can’t solve tomorrow’s needs if we keep using yesterday’s tools. That’s why Dohmen Life Science Services has developed a new approach to outsourcing. Many life science companies, from start-ups to established brands, recognize that working with multiple vendors is an unnecessary redundancy that adds cost and complexity – without adding value.


Let’s strengthen and simplify the relationships between your organization and your customers and patients. Even better, let’s continuously improve and provide value along the way.


From regulatory compliance to commercialization, our model represents a broad basket of services to help move your therapy from the bench to bedside. And it’s backed by the industry’s best experts.


Rare disease patients deserve a wrap-around care model designed specifically for them and your therapy. Everything from onboarding to reimbursement to patient education, all under one roof.

Evolve your business

Change starts with a conversation. And results improve with collaboration. Tell us a bit about yourself. Let’s create something great.